FEATURED COMPANIES
- Abbott
- AngioDynamic, Inc
- Biosense Webster Inc
- Diros Technology, Inc
- Medtronic plc
- NeuroTherm Inc
Global Radiofrequency Ablation Devices for Pain Management Market to Reach $1.3 Billion by 2027
Amid the COVID-19 crisis, the global market for Radiofrequency Ablation Devices for Pain Management estimated at US$589.2 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 11.7% over the analysis period 2020-2027. RF Generators, one of the segments analyzed in the report, is projected to record a 12.8% CAGR and reach US$487.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reusable Products segment is readjusted to a revised 11.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $159 Million, While China is Forecast to Grow at 15.5% CAGR
The Radiofrequency Ablation Devices for Pain Management market in the U.S. is estimated at US$159 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$280.5 Million by the year 2027 trailing a CAGR of 15.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 10.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.
Disposable Products Segment to Record 10.8% CAGR
In the global Disposable Products segment, USA, Canada, Japan, China and Europe will drive the 10.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$206 Million in the year 2020 will reach a projected size of US$404 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$186.9 Million by the year 2027, while Latin America will expand at a 12.3% CAGR through the analysis period.
Select Competitors (Total 46 Featured):
Amid the COVID-19 crisis, the global market for Radiofrequency Ablation Devices for Pain Management estimated at US$589.2 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 11.7% over the analysis period 2020-2027. RF Generators, one of the segments analyzed in the report, is projected to record a 12.8% CAGR and reach US$487.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reusable Products segment is readjusted to a revised 11.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $159 Million, While China is Forecast to Grow at 15.5% CAGR
The Radiofrequency Ablation Devices for Pain Management market in the U.S. is estimated at US$159 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$280.5 Million by the year 2027 trailing a CAGR of 15.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 10.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.
Disposable Products Segment to Record 10.8% CAGR
In the global Disposable Products segment, USA, Canada, Japan, China and Europe will drive the 10.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$206 Million in the year 2020 will reach a projected size of US$404 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$186.9 Million by the year 2027, while Latin America will expand at a 12.3% CAGR through the analysis period.
Select Competitors (Total 46 Featured):
- Abbott
- Accuray, Inc
- AngioDynamic, Inc
- Avanos Medical Inc
- Biosense Webster Inc
- Boston Scientific Corporation
- Cosman Medica, Inc
- Diros Technology, Inc
- Halyard Health, Inc
- Kimberly-Clark Corporation
- Medtronic plc
- Merit Medical Systems
- NeuroTherm Inc
- Olympus Corporation
- St. Jude Medical, Inc
- Stryker Corporation
Frequently Asked Questions about the Global Market for Radiofrequency Ablation Devices for Pain Management
What is the estimated value of the Global Market for Radiofrequency Ablation Devices for Pain Management?
What is the growth rate of the Global Market for Radiofrequency Ablation Devices for Pain Management?
What is the forecasted size of the Global Market for Radiofrequency Ablation Devices for Pain Management?
Who are the key companies in the Global Market for Radiofrequency Ablation Devices for Pain Management?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott
- AngioDynamic, Inc
- Biosense Webster Inc
- Diros Technology, Inc
- Medtronic plc
- NeuroTherm Inc
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Abbott
- Accuray, Inc
- AngioDynamic, Inc
- Avanos Medical Inc
- Biosense Webster Inc
- Boston Scientific Corporation
- Cosman Medica, Inc
- Diros Technology, Inc
- Halyard Health, Inc
- Kimberly-Clark Corporation
- Medtronic plc
- Merit Medical Systems
- NeuroTherm Inc
- Olympus Corporation
- St. Jude Medical, Inc
- Stryker Corporation
Note: Product cover images may vary from those shown